Friday, October 04, 2019 11:44:37 AM
Sirona's breakthrough with the Rodan + Fields agreement for skin lightening enables the company to focus on multiple catalysts now.
CEO Howard Verrico anticipates "multiple positive events within the next six months, hopefully much sooner".
Key catalysts are the anticipated skin lightening deal for the Chinese market and a partnership for the anti-aging / anti-wrinkle compounds.
The article discusses all known catalysts and reconfirms the investment thesis.
article on seekingalpha
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM